Table 2. Clinical and genetic characteristics of 51 patients with gliomas.

Features	All (n = 51)	LGG (n = 16)	GBM (n = 35)
Sex
Male	60.78% (31/51)	50.00% (8/16)	65.71% (23/35)
Female	39.22% (20/51)	50.00% (8/16)	34.29% (12/35)
Age
Median (Range)	51.41 (24–73)	47.38 (24–64)	53.26 (24–73)
Tumor location
Frontal lobe	33.33% (17/51)	37.50% (6/16)	31.43% (11/35)
Temporal lobe	33.33% (17/51)	25.00% (4/16)	37.14% (13/35)
Two or more lobes	29.41% (15/51)	37.50% (6/16)	25.71% (9/35)
Other	3.92% (2/51)	-	5.71% (2/35)
IDH1
Mutation	25.49% (13/51)	43.75% (7/16)	17.14% (6/35)
Wild-type	74.51% (38/51) (38/51)	56.25% (9/16)	82.86% (29/35)
TERTp
Mutation	60.78% (31/51)	56.25% (9/16)	62.86% (22/35)
Wild-type	39.22% (20/51)	43.75% (7/16)	37.14% (13/35)
Survival
Yes	23.40% (11/47)	60.00% (9/15)	6.25% (2/32)
No	76.60% (36/47)	40.00% (6/15)	93.75% (30/32)